Earnings Call · Q2 FY2021·2021-08-09

Q2 21EPS +38.89%·Rev n/aQ1 21EPS +11.11%·Rev n/aQ4 20EPS +7.69%·Rev n/aQ3 20EPS +33.33%·Rev n/a⚠ consensus missing

Amneal Pharmaceuticals, Inc. AMRX

Tony DiMeo — Head of Investor Relations

Chirag Patel — Chief Executive Officer (CEO)

Chintu Patel — Executive (likely Operations or Quality leadership)

Tasos Konidaris — Executive (likely CFO or Finance leadership)

+5.5%1d on move date+5.6% vs SPY3d+3.5%5d+4.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMRX calls or request research access.

More AMRX calls Browse calls Request research access